Search clinical trials for: Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):6L/min

Total 23 results

University Hospital, Ghent

Completed

Clinical Study to Determine the Optimal Operation Parameters During CO2 Removal With the Abylcap® System

ARDS (Acute Respiratory Distress Syndrome) | Respiratory Acidosis

Belgium
Asan Medical Center

Completed

Effect of Fresh Gas Flow on Emergence Time

Bladder Cancer

Korea, Republic of
Ufuk University

Recruiting

Desflurane and Sevoflurane Minimal Flow Anesthesia on Recovery and Anesthetic Depth

Anesthesia

Turkey
Prof. Dr. Cemil Tascıoglu Education and Research...

Completed

Effect of Low Flow Anesthetics on Neurocognitive Decline in the Elderly

Neurocognitive Disorders | Inhalation; Vapor

Turkey
Connecticut Children's Medical Center
University of Connecticut

Recruiting

The Impact of Blood Flow Restriction Training in Adolescents After ACL Reconstruction: A Randomized Controlled Trial

Anterior Cruciate Ligament Injuries | Knee Injuries | Quadriceps Muscle Atrophy

United States
Connecticut Children's Medical Center

Completed

Blood Flow Restriction Training (BFR) in an Adolescent Population

ACL Injury | Blood Flow Restriction | ACL Tear

United States
Medipost Co Ltd.

Completed

Evaluate Safety and Explore Efficacy of SMUP-IA-01 in Patients With Knee Osteoarthritis

Knee Osteoarthritis

Korea, Republic of
Medipost Co Ltd.

Recruiting

Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial

Knee Osteoarthritis

Korea, Republic of
Medipost Co Ltd.

Recruiting

Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis

Knee Osteoarthritis

Korea, Republic of
University of Colorado, Boulder
Forest Laboratories

Completed

Nebivolol and the Endothelin (ET)-1 System (NETS)

Hypertension | Prehypertension

United States
Joanneum Research Forschungsgesellschaft mbH

Completed

An Exploratory Study in Healthy Volunteers to Investigate the Cross-talk Between Local Drug Concentrations in the Skin and Systemic Concentrations During Topical Bioequivalence Studies Using Dermal Sampling Techniques

Healthy | Dermal Pharmacokinetic Measurement

Austria
Université de Montréal
Genzyme, a Sanofi Company

Completed

Clinical Investigation on the Blood Oxygenation at the Optic Nerve Head in Fabry Patients

Fabry Disease

Canada
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Institute of Allergy and Infectious...

Terminated

Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases

Myelodysplastic Syndromes | Leukemia | Graft Versus Host Disease

United States
Stefan Soderberg
University of Edinburgh

Completed

Leptin Infusion and Endothelial Vasomotor Response (LIVARM)

Obesity | Endothelial Dysfunction | Vasodilation | Venous Occlusion Plethysmography

Sweden, United Kingdom
Scottish Cancer Therapy Network

Completed

Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Breast Cancer

United Kingdom, Ireland
ETOP IBCSG Partners Foundation

Completed

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer (15-95)

Breast Cancer

Switzerland, Australia
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma

Lymphoma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Completed

Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Recurrent Adult Acute Myeloid Leukemia | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult... and other conditions

United States, Germany
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Lymphoma | Leukemia

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia

Leukemia

United States, Australia, Canada
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia

Leukemia

United States, Australia, Canada
Memorial Sloan Kettering Cancer Center
Tufts Medical Center; Lahey Clinic

Completed

Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L

Multiple Myeloma

United States
National Cancer Institute (NCI)

Active, not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Glioma | Hematopoietic and Lymphoid Cell Neoplasm | Melanoma | Lymphoma | Multiple Myeloma | Recurrent Ovarian Carcinoma | Breast Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Skin Carcinoma | Gastric Carcinoma | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory... and other conditions

United States, Puerto Rico, Guam

Search clinical trials for: Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):6L/min

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations